The relative number of macrophages/microglia expressing macrophage colony‐stimulating factor and its receptor decreases in multiple sclerosis lesions
- 26 August 2002
- Vol. 40 (1) , 121-129
- https://doi.org/10.1002/glia.10120
Abstract
The activation of macrophages/microglia in multiple sclerosis (MS) lesions plays a central role in the effector phase of myelin breakdown. The precise patterns of macrophage/microglia activation during demyelination have not yet been defined. The growth and activating factor macrophage‐colony stimulating factor (M‐CSF) and its specific receptor (M‐CSFR) may be involved in this process. The present study investigated the expression of M‐CSF and M‐CSFR mRNA by in situ hybridization in 60 lesions from 32 MS patients. In the control and periplaque white matter, microglia was almost completely M‐CSFR positive. Irrespective of the demyelinating activity, an increased number of cells expressed M‐CSF or M‐CSFR mRNA within the lesions. However, despite the tremendous increase in macrophages/microglia within the lesions, the relative number of these cells expressing M‐CSF or M‐CSFR decreased. There was no correlation of M‐CSF or M‐CSFR expression with active myelin breakdown. The correlation between the clinical course and the expression of M‐CSF or M‐CSFR mRNA revealed significant differences with the lowest expression in primary progressive MS. These results suggest a downregulation of M‐CSF and M‐CSFR inside the MS plaque probably due to the high amount of macrophage‐derived cytokines or mediators. Nevertheless, the differences in the relative number of cells expressing the M‐CSF/M‐CSFR pathway implicate that this pathway may be an important contributory factor in different forms of MS pathology. GLIA 40:121–129, 2002.Keywords
Funding Information
- Gemeinnützige Hertie-Stiftung
This publication has 42 references indexed in Scilit:
- Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesionsJournal of Neuroimmunology, 1998
- M-CSF: HAEMATOPOIETIC GROWTH FACTOR OR INFLAMMATORY CYTOKINE?Cytokine, 1998
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitisGlia, 1995
- Monocyte/macrophage differentiation in early multiple sclerosis lesionsAnnals of Neurology, 1995
- Microglia in colony‐stimulating factor 1‐deficient op/op miceJournal of Neuroscience Research, 1995
- Immunological Aspects of Experimental Allergic Encephalomyelitis and Multiple SclerosisCritical Reviews in Clinical Laboratory Sciences, 1995
- Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages.The Journal of Experimental Medicine, 1990
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983